This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
Login or create an account to see restricted content
Login or RegisterThe EXAMINE CVOT assessed the cardiovascular safety of alogliptin in patients with type 2 diabetes and acute coronary syndrome. This module details the study outcomes.